Lenskart IPO: Allotment odds, GMP shift, key dates
Lenskart IPO: Allotment odds, GMP shift, key dates
Lenskart's IPO drew strong investor interest with a Rs 382-402 price band; allotment odds by category and key dates explained as GMP cools.
Lenskart Solutions is set to finalize the basis of allotment on Thursday, November 6, with bidders receiving updates for debit of funds or revocation of their IPO mandate by Friday, November 7. The eyewear retailer drew strong demand, opening for subscription from October 31 to November 4 and raising around Rs 7,278 crore through a mix of a fresh issue and an offer-for-sale. The issue was priced in a band of Rs 382-402 per share with a lot size of 37 shares.
The issue saw robust overall subscription, attracting bids more than 28 times the issue size and receiving over 32.56 lakh applications. Qualified institutional bidders subscribed 40.35 times, non-institutional investors 18.23 times, retail investors 7.54 times, and employees 4.95 times. Based on the bidding pattern, the odds of allotment are as follows: in the big HNI category, 3 investors out of 13 are expected to receive 518 shares (23.08% probability); in the small HNI category, 2 out of 21 investors will get 518 shares (9.52%); and in the retail category, 1 out of 6 investors will receive 25 shares (16.67%).
The grey market premium for Lenskart Solutions has cooled after the initial surge, despite the strong demand seen during bidding. Investors tracking the IPO should watch for official allotment confirmations and the debit/mandate status messages, as these will determine who gets shares and how much up-front funding is required.
For those awaiting outcomes, the key dates remain the finalization of the allotment basis on November 6 and the subsequent debit notices by November 7. As always, potential investors should align their expectations with the category odds and the broader market environment before making post-listing decisions.
Cover image source: Lenskart Solutions IPO: Check application status, odds of allotment, latest GMP & more đź”—